Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

Since the emergence of SARS-CoV-2, vaccines targeting COVID-19 have been developed with unprecedented speed and efficiency. CoronaVac, utilising an inactivated form of the COVID-19 virus and the mRNA26 based Pfizer/BNT162b2 vaccines are widely distributed. Beyond the ability of vaccines to induce pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, X., McNamara, R. P., Avendaño, M. J., Serrano, E. F., García-Salum, T., Pardo-Roa, C., Bertera, H. L., Chicz, T. M., Levican, J., Poblete, E., Salinas, E., Muñoz, A., Riquelme, A., Alter, G., Medina, R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/
https://www.ncbi.nlm.nih.gov/pubmed/37443074
http://dx.doi.org/10.1038/s41467-023-39189-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345146/
https://www.ncbi.nlm.nih.gov/pubmed/37443074
http://dx.doi.org/10.1038/s41467-023-39189-8

Ejemplares similares